Phibro Animal Health PAHC
NASDAQ PAHC
$35.18 -0.26 (-0.73%)
As of: Aug 20, 2026 · 3:59 PM EDT

Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022)

Phibro Animal Health (PAHC) posted quarterly Non-Current Deferred Tax Liability of $8.8 million for Q1 2022, down 28.45% year-over-year from $12.4 million in Q1 2021, and up 9.72% quarter-over-quarter from $8.1 million in Q4 2021.

Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022) Analysis & Trends

Phibro Animal Health's Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $8.8 million for Q1 2022.

  • In Q1 2022, Non-Current Deferred Tax Liability fell 28.45% year-over-year to $8.8 million; the TTM figure through Mar 2022 stood at $8.8 million (down 28.45% YoY), while the FY2021 annual figure was $6.6 million, up 451.54% from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2022 stood at $8.8 million, up from $8.1 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $12.4 million in Q1 2021, with the low at $1.2 million in Q2 2020.
  • The 4-year median for Non-Current Deferred Tax Liability is $8.8 million (2022), against an average of $7.8 million.
  • The sharpest annual moves came in 2020 and 2021: Non-Current Deferred Tax Liability sank 36.07% in 2020, then surged 451.54% in 2021.
  • Phibro Animal Health's Non-Current Deferred Tax Liability stood at $9.5 million in 2019, then advanced by 26.6% to $12.1 million in 2020, then tumbled by 33.09% to $8.1 million in 2021, then rose by 9.72% to $8.8 million in 2022.
  • Business Quant data shows PAHC's Non-Current Deferred Tax Liability at $8.8 million in Q1 2022, $8.1 million in Q4 2021, and $7.3 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Phibro Animal Health 1.42 Bn 1.35 Bn 125.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2022 8.85 Mn
Mar 31, 2022 8.85 Mn
Dec 31, 2021 8.06 Mn
Dec 31, 2021 8.06 Mn
Sep 30, 2021 7.30 Mn
Sep 30, 2021 7.30 Mn
Jun 30, 2021 6.65 Mn
Jun 30, 2021 6.65 Mn
Mar 31, 2021 12.37 Mn
Mar 31, 2021 12.37 Mn
Dec 31, 2020 12.05 Mn
Dec 31, 2020 12.05 Mn
Jun 30, 2020 1.21 Mn
Jun 30, 2020 1.21 Mn
Mar 31, 2020 9.29 Mn
Mar 31, 2020 9.29 Mn
Dec 31, 2019 9.52 Mn
Dec 31, 2019 9.52 Mn
Sep 30, 2019 9.02 Mn
Sep 30, 2019 9.02 Mn